Related Experiment Video
Updated: Jun 21, 2026
08:32
Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017
Inhibition on inducible nitric oxide synthase
1Department of Medicinal Chemistr, University of Mississippi, MS 38677, USA. jrimoldi@cotton.vislab.olemiss.edu
Current Opinion in Drug Discovery & Development
|August 4, 2009
Summary
Nitric oxide synthase (NOS) inhibitors are crucial for managing diseases linked to excessive nitric oxide (NO) production. This review focuses on novel inhibitors targeting inducible NOS (iNOS) to control NO overproduction in various inflammatory conditions.
Area of Science:
- Biochemistry
- Pharmacology
- Immunology
Background:
- Nitric oxide (NO) plays a vital role in numerous physiological and pathophysiological processes.
- The inducible form of nitric oxide synthase (iNOS) is implicated in various diseases, including inflammatory conditions and shock.
- Uncontrolled NO overproduction by iNOS presents a significant therapeutic challenge.
Purpose of the Study:
- To review recent advancements in the identification and development of novel inhibitors targeting inducible nitric oxide synthase (iNOS).
- To explore therapeutic strategies for controlling excessive NO production in disease states.
Main Methods:
- Literature review of recent scientific publications on iNOS inhibitors.
- Analysis of therapeutic intervention strategies for modulating NO production.
- Focus on L-arginine competitive antagonists and irreversible enzyme inhibitors of iNOS.
Main Results:
- The exponential growth in NO-related research highlights its complex roles.
- Various strategies exist to control iNOS activity, from preventing mRNA expression to inhibiting NO action.
- Novel inhibitors are being developed to specifically target iNOS.
Conclusions:
- Controlling iNOS-mediated NO overproduction is critical for treating associated diseases.
- Development of novel iNOS inhibitors represents a promising therapeutic avenue.
- Further research into iNOS inhibition is warranted for effective disease management.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
00:46Feedback Inhibition
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...